Trial
NCT02286258
Validation of New Markers of Glomerular Filtration Rate: Dota Gadolinium and Calcium EDTA (MultiGFR)
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Assistance Publique - Hôpitaux de Paris
Collaborators
Ministry of Health, France
Condition
Renal Insufficiency, Chronic
Intervention
Calcium EDTA
Why stopped
The study was suspended after a suspected unexpected serious adverse event.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-05-18